A Trial of Infant Flow Biphasic Nasal Continuous Airway Pressure (NCPAP) Versus Infant Flow NCPAP for the Facilitation of Extubation in Infants </= 1250 Grams
Infant Flow Biphasic NCPAP Versus Infant Flow NCPAP for the Facilitation of Successful Extubation in Infants </= 1250 Grams: A Randomized Controlled Trial
Sponsor: Mount Sinai Hospital, Canada
Terminated
Poor enrollment
Other terminated trials from Mount Sinai Hospital, Canada
Other Apnea of Prematurity trials with similar outcome
Listed as NCT00308789, this PHASE2 trial focuses on Apnea of Prematurity and Bronchopulmonary Dysplasia and remains terminated or withdrawn. Sponsored by Mount Sinai Hospital, Canada, it has been updated 5 times since 2006, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE2
First recorded
Apr 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Mount Sinai Hospital, Canada
- The Physicians' Services Incorporated Foundation
For direct contact, visit the study record on ClinicalTrials.gov .